insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

SFE · Safeguard Scientifics Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Sign in to download
AnnualQuarterly

Income Statement

Line itemQ4 '23Q3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21
Revenue----------
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A-$1.31M$1.19M$1.19M-$1.36M$1.15M$1.23M-$1.56M
Total Operating Expenses----------
D&A----------
Operating Income-($1.31M)($1.19M)($1.19M)-($1.36M)($1.15M)($1.23M)-($1.56M)
Interest Expense----------
Income Tax-$0$0$0-$0$0--$0
Net Income-$932.0K($2.86M)($3.48M)-($3.16M)$483.0K($6.71M)-$18.33M
EPS - Basic-$0.06($0.18)($0.22)-($0.19)$0.03($0.40)-$0.88
EPS - Diluted-$0.06($0.18)($0.22)-($0.19)$0.03($0.40)-$0.88

Balance Sheet

Line itemQ4 '23Q3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21
Cash & Equivalents$9.50M$15.66M$14.25M$11.01M$13.33M$15.03M$17.51M$19.41M$24.74M$15.60M
Accounts Receivable----------
Inventory----------
Accounts Payable$107.0K$103.0K$67.0K$71.0K$16.0K$9.0K$56.0K$0$41.0K$77.0K
Current Assets$9.91M$16.28M$16.73M$20.14M$21.42M$23.81M$21.07M$22.90M$30.28M$76.37M
Total Assets$22.84M$32.43M$31.08M$33.73M$37.69M$43.39M$45.96M$46.20M$54.03M$69.03M
Current Liabilities$2.05M$1.56M$1.26M$1.15M$1.82M$1.87M$1.14M$1.01M$1.73M$3.90M
Long-term Debt----------
Total Liabilities$2.86M$2.50M$2.32M$2.33M$3.12M$3.28M$2.66M$2.65M$3.46M$6.16M
Stockholders' Equity$19.98M$29.93M$28.76M$31.39M$34.58M$40.11M$43.30M$43.55M$50.57M$62.88M
Retained Earnings($733.73M)($729.31M)($730.24M)($727.38M)($723.90M)($719.02M)($715.86M)($716.34M)($709.63M)($701.00M)

Cash Flow

Line itemQ4 '23Q3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21
Operating Cash Flow---($928.0K)---($1.00M)--
Investing Cash Flow---($1.09M)---($3.10M)--
Financing Cash Flow---($305.0K)---($1.23M)--
CapEx----------
Free Cash Flow----------

Ratios

MetricQ4 '23Q3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21
Profitability
Gross margin----------
Operating margin----------
EBITDA margin----------
Net margin----------
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate-0.0%----0.0%--0.0%
Return on assets-2.9%-9.2%-10.3%--7.3%1.1%-14.5%-26.6%
Return on equity-3.1%-10.0%-11.1%--7.9%1.1%-15.4%-29.2%
Return on invested capital----------
Liquidity
Current ratio4.8410.4113.3217.4811.7912.7318.4522.6717.4619.59
Quick ratio4.8410.4113.3217.4811.7912.7318.4522.6717.4619.59
Cash ratio4.6410.0211.349.567.348.0315.3319.2114.274.00
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier1.141.081.081.071.091.081.061.061.071.10
Liabilities / Assets0.130.080.070.070.080.080.060.060.060.09
Efficiency
Asset turnover----------
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)----------
Revenue CAGR (3y)----------
Revenue CAGR (5y)----------
Gross profit growth (YoY)----------
Operating income growth (YoY)-3.5%-3.5%4.0%-13.0%42.4%49.9%-31.3%
Net income growth (YoY)---48.1%------
EPS growth (YoY)---45.0%------
EPS CAGR (3y)-------74.2%---17.4%
EPS CAGR (5y)--47.9%--------
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)-42.2%-25.4%-33.6%-27.9%-31.6%-36.2%-45.5%-46.2%-19.6%-10.5%

Peer comparison

Same SIC group: Investors, NEC

CompanyRevenue (last FY)Net marginROE
FOMC$7.52M-49.0%143.2%
HASI$400.50M46.1%6.9%
MNTR$166.8K-344.2%-24.8%
FIAC---
CBNT---

Comparing SAFEGUARD SCIENTIFICS INC against the 5 most active filers in the same SIC group.